title: Systemic and ocular immune responses in cattle following intranasal vaccination with precipitated or partially solubilized recombinant Moraxella bovis cytotoxin adjuvanted with polyacrylic acid.
abstract: OBJECTIVE To evaluate changes in systemic and ocular antibody responses of steers following intranasal vaccination with precipitated or partially solubilized recombinant Moraxella bovis cytotoxin (MbxA). ANIMALS 13 Angus steers with ages ranging from 318 to 389 days and weights ranging from 352 to 437 kg. PROCEDURES Steers were assigned to receive 500 μg of a precipitated (MbxA-P; n = 5) or partially solubilized (MbxA-S; 5) recombinant MbxA subunit adjuvanted with polyacrylic acid. A control group (n = 3) received the adjuvant alone. Each steer received the assigned treatment (1 mL/nostril) on days 0 and 28. Serum and tear samples were collected on days 0 (before vaccination), 14, 28, 42, and 55. Changes in MbxA-neutralizing antibody titers and MbxA-specific IgG concentrations in serum and tears and changes in MbxA-specific IgA concentrations in tears were measured. RESULTS Mean fold changes in MbxA-specific IgG concentration in serum and tears and MbxA-neutralizing antibody titer in tears for the MbxA-P group were significantly greater than those for the MbxA-S and control groups. Mean serum MbxA-neutralizing antibody titer did not differ among the 3 groups. Although the mean fold change in tear MbxA-specific IgA concentration differed significantly among the groups in the overall analysis, post hoc comparisons failed to identify any significant pairwise differences. CONCLUSIONS AND CLINICAL RELEVANCE Systemic and ocular immune responses induced by intranasal administration of the MbxA-P vaccine were superior to those induced by the MbxA-S vaccine. Additional research is necessary to determine whether the MbxA-P vaccine can prevent naturally occurring infectious bovine keratoconjunctivitis.
authors.forename: John A
authors.initials: JA
authors.lastname: Angelos
authors.forename: Munashe
authors.initials: M
authors.lastname: Chigerwe
authors.forename: Judy M
authors.initials: JM
authors.lastname: Edman
authors.forename: John F
authors.initials: JF
authors.lastname: Hess
mesh_terms: D000180:Acrylic Resins / Q000008:administration & dosage / Q000627:therapeutic use*; D000281:Administration, Intranasal / Q000662:veterinary; D000818:Animals; D002417:Cattle; D002418:Cattle Diseases / Q000097:blood / Q000276:immunology / Q000517:prevention & control*; D007639:Keratoconjunctivitis, Infectious / Q000276:immunology / Q000517:prevention & control*; D016955:Moraxella bovis / Q000276:immunology*; D014611:Vaccination / Q000662:veterinary; D022223:Vaccines, Subunit / Q000008:administration & dosage / Q000627:therapeutic use*
chemical_list: D000180:Acrylic Resins; D022223:Vaccines, Subunit; C006903:carbopol 940